Similarly, we used CRISPR/Cas9 to deplete NNMT in SKOV3 ovarian cancer cells (endometrioid/clear cell subtype [40]), a cell line previously shown to have high NNMT activity [41]. The gene discussed is NNMT; the disease is ovarian cancer.